Cornerstone Planning Group
PCRX icon

Cornerstone Planning Group’s Pacira BioSciences PCRX Stock Holding History

Cornerstone Planning Group’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-18
Closed -$461 – 1240
2026
Q2 		$461 Hold
18
– – ﹤0.01% 1717
2026
Q1 		$447 Hold
18
– – ﹤0.01% 1679
2025
Q4 		$367 Sell
18
-43
-70% -$1.02K ﹤0.01% 1577
2025
Q3 		$12K Buy
61
+43
+239% +$1.06K ﹤0.01% 728
2025
Q2 		$406 Hold
18
– – ﹤0.01% 1358
2025
Q1 		$454 Hold
18
– – ﹤0.01% 1330
2024
Q4 		$462 Buy
+18
New +$316 ﹤0.01% 1168

Other funds holding PCRX

Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Ellsworth Advisors
Ellsworth Advisors Hudson, Ohio $620M AUM 38.17% 1-Year Est. Return
Inspire Investing
Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Cornerstone Planning Group's PCRX Position: Q3 2026 in Review

Cornerstone Planning Group sold out of Pacira BioSciences (PCRX) in Q3 2026, closing a stake of 18 shares — an estimated $461 sold.

Cornerstone Planning Group first reported a position in PCRX in Q4 2024 and held it in 7 quarters. The position peaked at $12K in Q3 2025. 37 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.

  • Cornerstone Planning Group reported no remaining Pacira BioSciences position as of Q3 2026 after selling out during the quarter.
  • Cornerstone Planning Group sold 18 Pacira BioSciences shares in Q3 2026, an estimated $461.
  • Cornerstone Planning Group first reported a position in Pacira BioSciences in Q4 2024 and held it in 7 quarters.
  • Cornerstone Planning Group's Pacira BioSciences position peaked at $12K in Q3 2025.
  • 37 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.

Based on Cornerstone Planning Group's 13F filing for Q3 2026, filed 16 Oct 2026.